Skip to content
    Research Corporation Technologies logo

    Research Corporation Technologies

    Tucson, Arizona, United StatesFounded 1987
    rctech.comLinkedIn
    Biotech & Life SciencesHealthcare

    Research Corporation Technologies (RCT) is a Tucson, Arizona-based technology investment and management firm that provides early-stage venture funding and development for biomedical and life science companies, with technologies originating from universities and research institutions worldwide.

    Average disclosed round size is $29.8M (across 17 rounds with reported amounts).

    Find people at Research Corporation Technologies on Goldilocks AI

    Portfolio

    11

    Fund Size

    —

    Top Stage

    Series B

    Last 12 Mo

    0

    Team

    BM

    Brad Morie

    Senior Director, Biotechnologies

    DW

    Danielle Wilson

    Director of Administration & Corporate Secretary

    PH

    Paul Hoerbelt

    Director Biotechnologies

    CW

    Chad W. Souvignier, Ph.D

    Vice President

    DA

    David A. Wiersma

    Senior Associate

    MZ

    Maggie Zhou

    Associate Controller

    WK

    William Kelly

    Associate

    CP

    Christopher P. Martin

    President, Medical Devices & Chief Financial Officer

    JF

    Jorge Figueroa

    Systems Administrator

    KM

    Kathleen M. Hunter-Gregory

    Controller

    SA

    Shaun A. Kirkpatrick

    President, Biotechnologies

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    18 investments
    CompanyRoundAmountDate
    Pheon Therapeutics logoPheon TherapeuticsSeries B$120MMay 2024
    Pheon Therapeutics logoPheon TherapeuticsSeries A$68MSep 2022
    Halo Labs logoHalo LabsSeries C$6MJul 2022
    Pheon Therapeutics logoPheon TherapeuticsSeries A$68MMar 2022
    SSeqWell, IncSeries C$7MJan 2022
    SSeqWell, IncSeries B$9MJan 2020
    Halo Labs logoHalo LabsSeries B$5.6MJan 2019
    Threads logoThreadsSeries D$123MJan 2018
    Orthalign logoOrthalignSeries D$10MSep 2017
    BBiocisionGrowth$2.5MDec 2012
    EEsperance PharmaceuticalsSeries B$7.5MJan 2011
    Orthalign logoOrthalignSeries A$5.2MJan 2010
    EEsperance PharmaceuticalsUnknown$6MJan 2006
    Velio logoVelioUnknown$45MJul 2001
    CCyMedica OrthopedicsSeries A$11.5M—
    HHalo Labs, Inc.Series C$6M—
    HHalo Labs, Inc.Series B$5.6M—
    FFemtogenixSeries A——

    Top Co-Investors

    Atlas Venture4 shared
    Forbion4 shared
    Brandon Capital4 shared
    Lightspeed Venture Partners3 shared
    BroadOak Capital Partners3 shared
    CRG2 shared
    BVF Partners L.P.1 shared
    TCG Crossover1 shared
    TCG1 shared
    Perceptive Advisors1 shared
    Temasek Holdings (Private) Limited1 shared
    Slow Ventures1 shared
    Fidelity Investments1 shared
    Baillie Gifford1 shared
    Allen & Company LLC1 shared
    Founders Fund1 shared
    RC Capital1 shared
    Mutual Capital Partners1 shared
    Providence Ventures1 shared
    Redpoint Ventures1 shared

    Last updated: 20 October 2026